Read your favorite news, except the excluded topics, by you.
Register
No overlapping ads for registered users
wellness Canada sanctioned on tues the number one generic wine version of Danish drugmaker Novo Nordisk's Ozempic drug.
Ina news release, the department said the submission for a generic semaglutide injection by Indian drugmaker Dr. Reddy's Laboratories has been approved. It's currently still reviewing eight other submissions by different companies.
In the next few weeks and months, it said it expects to make decisions on these submissions.
Health Canada said it approved Dr. Reddy's submission after "a thorough review of evidence" found that the drug meets safety, efficacy and quality standards. It said this generic, like existing products, is indicated to be used for the "once-weekly treatment of adult patients with Type 2 diabetes to manage blood sugar levels."
Health Canada added that generic semaglutide drugs are "pharmaceutically equivalent" to the brand-name version.
"The availability of generic drugs is expected to have a positive impact in Canada, including potential cost savings for patients and the healthcare system," the department said in its news release.
It said it will continue to monitor the safety and effectiveness of all generic semaglutides.
More to come.
In today's interconnected world, staying informed about global events is more important than ever. ZisNews provides news coverage from multiple countries, allowing you to compare how different regions report on the same stories. This unique approach helps you gain a broader and more balanced understanding of international affairs. Whether it's politics, business, technology, or cultural trends, ZisNews ensures that you get a well-rounded perspective rather than a one-sided view. Expand your knowledge and see how global narratives unfold from different angles.
At ZisNews, we understand that not every news story interests everyone. That's why we offer a customizable news feed, allowing you to control what you see. By adding keywords, you can filter out unwanted news, blocking articles that contain specific words in their titles or descriptions. This feature enables you to create a personalized experience where you only receive content that aligns with your interests. Register today to take full advantage of this functionality and enjoy a distraction-free news feed.
Stay engaged with the news by interacting with stories that matter to you. Like or dislike articles based on your opinion, and share your thoughts in the comments section. Join discussions, see what others are saying, and be a part of an informed community that values meaningful conversations.
For a seamless news experience, download the ZisNews Android app. Get instant notifications based on your selected categories and stay updated on breaking news. The app also allows you to block unwanted news, ensuring that you only receive content that aligns with your preferences. Stay connected anytime, anywhere.
With ZisNews, you can explore a wide range of topics, ensuring that you never miss important developments. From Technology and Science to Sports, Politics, and Entertainment, we bring you the latest updates from the world's most trusted sources. Whether you are interested in groundbreaking scientific discoveries, tech innovations, or major sports events, our platform keeps you updated in real-time. Our carefully curated news selection helps you stay ahead, providing accurate and relevant stories tailored to diverse interests.
No comments yet.